| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_76e8b0ec2338a4a64112e7ad1ce2041d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 |
| filingDate |
2012-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d005bfe3876f7c1ef5401c501cbe6fe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12cdc99aec1e5d7f2bbca277d9084d44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88700f221363d8857c31c371a8761b5e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be6f814364cfa1a9ab63bbc7f7d44503 |
| publicationDate |
2012-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2012214502-A |
| titleOfInvention |
Quinazoline derivatives, their preparation and use |
| abstract |
Kind Code: A1 The present invention provides a quinazoline derivative, its preparation and use. The present application discloses quinazoline derivatives of formula (I) and pharmaceutically acceptable salts or solvates thereof wherein the substituent definitions are the same as described. The present application also discloses these methods of preparation, compositions containing them, and their use in the preparation of therapeutic agents for anticoplastic diseases. The present invention also provides a pharmaceutical composition comprising 0.05 to 100 mg of a compound of formula I or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier, excipient or diluent. [Selection figure] None |
| priorityDate |
2006-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |